U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747389) titled 'A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder' on July 30.
Brief Summary: The purpose of the study is to assess how well each dose of lumateperone (Dose 1 and 2) works when given alone as compared to placebo in participants with major depressive disorder (MDD; a medical condition characterized by a persistent feeling of deep sadness, hopelessness, and a loss of interest in activities for a prolonged period of time and interfere with ability to function).
Study Start Date: Oct. 20
Study Type: INTERVENTIONAL
Condition:
Depressive Disorder, Major
Intervention:
DRUG: Lumateperone
Participant...